Literature DB >> 28100498

The Predominant CD4+ Th1 Cytokine Elicited to Chlamydia trachomatis Infection in Women Is Tumor Necrosis Factor Alpha and Not Interferon Gamma.

Stephen J Jordan1, Kanupriya Gupta1, Brian M O Ogendi1, Rakesh K Bakshi1, Richa Kapil1, Christen G Press1, Steffanie Sabbaj1, Jeannette Y Lee2, William M Geisler3.   

Abstract

Chlamydia trachomatis infection is the most prevalent bacterial sexually transmitted infection and can cause significant reproductive morbidity in women. There is insufficient knowledge of C. trachomatis-specific immune responses in humans, which could be important in guiding vaccine development efforts. In contrast, murine models have clearly demonstrated the essential role of T helper type 1 (Th1) cells, especially interferon gamma (IFN-γ)-producing CD4+ T cells, in protective immunity to chlamydia. To determine the frequency and magnitude of Th1 cytokine responses elicited to C. trachomatis infection in humans, we stimulated peripheral blood mononuclear cells from 90 chlamydia-infected women with C. trachomatis elementary bodies, Pgp3, and major outer membrane protein and measured IFN-γ-, tumor necrosis factor alpha (TNF-α)-, and interleukin-2 (IL-2)-producing CD4+ and CD8+ T-cell responses using intracellular cytokine staining. The majority of chlamydia-infected women elicited CD4+ TNF-α responses, with frequency and magnitude varying significantly depending on the C. trachomatis antigen used. CD4+ IFN-γ and IL-2 responses occurred infrequently, as did production of any of the three cytokines by CD8+ T cells. About one-third of TNF-α-producing CD4+ T cells coproduced IFN-γ or IL-2. In summary, the predominant Th1 cytokine response elicited to C. trachomatis infection in women was a CD4+ TNF-α response, not CD4+ IFN-γ, and a subset of the CD4+ TNF-α-positive cells produced a second Th1 cytokine.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Chlamydia trachomatis; Th1 responses; tumor necrosis factor

Mesh:

Substances:

Year:  2017        PMID: 28100498      PMCID: PMC5382828          DOI: 10.1128/CVI.00010-17

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  47 in total

1.  Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics.

Authors:  Xiaoyun Liu; Mary Afrane; David E Clemmer; Guangming Zhong; David E Nelson
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

2.  Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid.

Authors:  D J Conway; M J Holland; R L Bailey; A E Campbell; O S Mahdi; R Jennings; E Mbena; D C Mabey
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 3.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

4.  Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma.

Authors:  Craig R Cohen; Kasra M Koochesfahani; Amalia S Meier; Caixia Shen; Karuna Karunakaran; Beartrice Ondondo; Teresa Kinyari; Nelly R Mugo; Rosemary Nguti; Robert C Brunham
Journal:  J Infect Dis       Date:  2005-07-07       Impact factor: 5.226

5.  Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.

Authors:  J Judy Chang; Fiona Wightman; Angeline Bartholomeusz; Anna Ayres; Stephen J Kent; Joseph Sasadeusz; Sharon R Lewin
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  Immunoglobulin-specific responses to Chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection.

Authors:  William M Geisler; Sandra G Morrison; Martha L Doemland; Shehzad M Iqbal; Jin Su; Ausra Mancevski; Edward W Hook; Richard P Morrison
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

8.  Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis.

Authors:  B P Katz; B E Batteiger; R B Jones
Journal:  Sex Transm Dis       Date:  1987 Jul-Sep       Impact factor: 2.830

9.  The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group.

Authors:  R C Brunham; J Kimani; J Bwayo; G Maitha; I Maclean; C Yang; C Shen; S Roman; N J Nagelkerke; M Cheang; F A Plummer
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

10.  Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.

Authors:  Douglas V Dolfi; Kathleen D Mansfield; Raj K Kurupati; Senthil Kannan; Susan A Doyle; Hildegund C J Ertl; Kenneth E Schmader; E John Wherry
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

View more
  10 in total

1.  Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis Infection.

Authors:  Sally A Harrison; Kristin M Olson; Amy E Ratliff; Li Xiao; Barbara Van Der Pol; Ken B Waites; William M Geisler
Journal:  Sex Transm Dis       Date:  2019-10       Impact factor: 2.830

2.  T cell phenotypes in women with Chlamydia trachomatis infection and influence of treatment on phenotype distributions.

Authors:  Brian M O Ogendi; Rakesh K Bakshi; Kanupriya Gupta; Richa Kapil; LaDraka T Brown; Stephen J Jordan; Steffanie Sabbaj; Christen G Press; Jeannette Y Lee; William M Geisler
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

3.  Stimulated peripheral blood mononuclear cells from chlamydia-infected women release predominantly Th1-polarizing cytokines.

Authors:  Stephen J Jordan; Rakesh K Bakshi; LaDraka' T Brown; Xiaofei Chi; William M Geisler
Journal:  Cytokine       Date:  2018-06-18       Impact factor: 3.861

Review 4.  Impact of Helminth Infections on Female Reproductive Health and Associated Diseases.

Authors:  Alisha Chetty; Millicent A Omondi; Claire Butters; Katherine Ann Smith; Gnatoulma Katawa; Manuel Ritter; Laura Layland; William Horsnell
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

5.  Vaccines: Underlying Principles of Design and Testing.

Authors:  Sallay Kallon; Shahryar Samir; Nilu Goonetilleke
Journal:  Clin Pharmacol Ther       Date:  2021-03-11       Impact factor: 6.875

6.  Molecular Evaluation of Chlamydia trachomatis Infection and Its Association with Tumor Necrosis Factor-α Polymorphism in Recurrent Spontaneous Abortions.

Authors:  Fatemeh Darvishi Kolor; Jalil Vand Yousefi; Reza Ranjbar
Journal:  Ethiop J Health Sci       Date:  2021-11

7.  PKCδ-Mediated Nox2 Activation Promotes Fluid-Phase Pinocytosis of Antigens by Immature Dendritic Cells.

Authors:  Bhupesh Singla; Pushpankur Ghoshal; Huiping Lin; Qingqing Wei; Zheng Dong; Gábor Csányi
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

8.  The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses.

Authors:  Richa Verma; Rajnish Sahu; Saurabh Dixit; Skyla A Duncan; Guillermo H Giambartolomei; Shree R Singh; Vida A Dennis
Journal:  Front Immunol       Date:  2018-10-15       Impact factor: 7.561

9.  An Adaptive Chlamydia trachomatis-Specific IFN-γ-Producing CD4+ T Cell Response Is Associated With Protection Against Chlamydia Reinfection in Women.

Authors:  Rakesh K Bakshi; Kanupriya Gupta; Stephen J Jordan; Xiaofei Chi; Shelly Y Lensing; Christen G Press; William M Geisler
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

10.  Antigen-specific memory and naïve CD4+ T cells following secondary Chlamydia trachomatis infection.

Authors:  Jennifer D Helble; Alexander O Mann; Michael N Starnbach
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.